Literature DB >> 25070044

Anterior pituitary autoantibodies in patients with type 1 diabetes mellitus: methodological problems and clinical correlations.

C Pisanu1, C Cocco, E Cossu, M G Baroni, F Pigliaru, L Manetti, I Lupi, E Martino, S Mariotti.   

Abstract

BACKGROUND: Anti-pituitary antibodies (APA) were described in patients with Type 1 Diabetes (T1D) but their prevalence and relevance remain controversial.
MATERIALS AND METHODS: We evaluated the APA prevalence in Sardinian sera from 100 T1D patients, 70 Type 2 Diabetes (T2D) patients and 62 healthy controls, using indirect immunofluorescence on bovine pituitary sections. To compare two different substrates, we tested using bovine sections, further T1D patient sera (n = 11, from Pisa) previously analysed for APA on monkey sections, while some T1D Sardinian patient sera (n = 22) were tested on monkey sections. According to preliminary experiments, positivity were considered ≥1:200 and ≥1:20 for bovine and monkey substrates, respectively. RESULTS AND DISCUSSION: Using bovine sections, APA were detected in 7/100 Sardinian T1D patients (at 1:200 titer) and in none of the other Sardinian sera tested. When the T1D sera from Pisa were tested on bovine and the T1D Sardinian sera were tested on monkey, none of these sera showed corresponding positivity for APA. Pituitary hormone dysfunctions were not found in the 7 APA-positive Sardinian T1D patients. The present study shows that the presence of APA at low-titer is highly related to T1D but not associated with any pituitary dysfunction while the animal species used as substrate appears crucial.
CONCLUSION: Further studies are needed to ascertain whether APA detected by different animal species may have different pathological relevance in T1D and/or whether APA in the long run may predict future anterior pituitary dysfunction.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25070044     DOI: 10.1007/s40618-014-0135-0

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  26 in total

1.  Predictive role of the immunostaining pattern of immunofluorescence and the titers of antipituitary antibodies at presentation for the occurrence of autoimmune hypopituitarism in patients with autoimmune polyendocrine syndromes over a five-year follow-up.

Authors:  Giuseppe Bellastella; Mario Rotondi; Elena Pane; Assunta Dello Iacovo; Barbara Pirali; Liliana Dalla Mora; Alberto Falorni; Antonio Agostino Sinisi; Antonio Bizzarro; Annamaria Colao; Luca Chiovato; Annamaria De Bellis
Journal:  J Clin Endocrinol Metab       Date:  2010-05-25       Impact factor: 5.958

2.  Thyroid autoimmunity in children with coexisting type 1 diabetes mellitus and celiac disease: a multicenter study.

Authors:  Z Sumnik; O Cinek; N Bratanic; J Lebl; B Rozsai; C Limbert; M Paskova; E Schober
Journal:  J Pediatr Endocrinol Metab       Date:  2006-04       Impact factor: 1.634

Review 3.  The association between autoimmune thyroiditis, autoimmune gastritis and type 1 diabetes.

Authors:  Wai-Kwan Lam-Tse; Manou R Batstra; Bobby P C Koeleman; Bart O Roep; Mu G J Bruining; Henk Jan Aanstoot; Hemmo A Drexhage
Journal:  Pediatr Endocrinol Rev       Date:  2003-09

4.  Presence of anti-pituitary antibodies and GAD antibodies in NIDDM and IDDM.

Authors:  T Kobayashi; S Yabe; T Kikuchi; T Kanda; I Kobayashi
Journal:  Diabetes Care       Date:  1997-05       Impact factor: 19.112

5.  Pituitary autoantibodies in autoimmune polyendocrine syndrome type 1.

Authors:  Sophie Bensing; Sergueï O Fetissov; Jan Mulder; Jaakko Perheentupa; Jan Gustafsson; Eystein S Husebye; Mikael Oscarson; Olov Ekwall; Patricia A Crock; Tomas Hökfelt; Anna-Lena Hulting; Olle Kämpe
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-10       Impact factor: 11.205

6.  Frequent delay of coeliac disease diagnosis in symptomatic patients with type 1 diabetes mellitus: clinical and genetic characteristics.

Authors:  Sjoerd F Bakker; Maarten E Tushuizen; Wilhelmina H Stokvis-Brantsma; Henk J Aanstoot; Per Winterdijk; Petra A van Setten; Boudewina M von Blomberg; Chris J Mulder; Suat Simsek
Journal:  Eur J Intern Med       Date:  2013-02-12       Impact factor: 4.487

7.  Long-term follow-up of organ-specific antibodies and related organ dysfunction in type 1 diabetes mellitus.

Authors:  L C G de Graaff; P Martín-Martorell; J Baan; B Ballieux; J W A Smit; J K Radder
Journal:  Neth J Med       Date:  2011-02       Impact factor: 1.422

8.  Heterogeneity of anterior pituitary cell antibodies detected in insulin-dependent diabetes mellitus and adrenocorticotropic hormone deficiency.

Authors:  M Sugiura; A Hashimoto; M Shizawa; M Tsukada; S Maruyama; T Ishido; T Kasahara; Y Hirata
Journal:  Diabetes Res       Date:  1986-03

9.  Median eminence dopaminergic nerve terminals: a novel target in autoimmune polyendocrine syndrome?

Authors:  Cristina Cocco; Antonella Meloni; Francesco Boi; Giovanni Pinna; Roberta Possenti; Stefano Mariotti; Gian-Luca Ferri
Journal:  J Clin Endocrinol Metab       Date:  2005-04-26       Impact factor: 5.958

10.  Studies on circulating anti-pituitary antibodies in NIDDM patients.

Authors:  T Kobayashi; S Yabe; T Kanda; I Kobayashi
Journal:  Endocr J       Date:  1998-06       Impact factor: 2.349

View more
  1 in total

Review 1.  The Hypothalamic-Pituitary Axis and Autoantibody Related Disorders.

Authors:  Cristina Cocco; Carla Brancia; Giulia Corda; Gian-Luca Ferri
Journal:  Int J Mol Sci       Date:  2017-11-03       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.